DAVITA INC. Proceeds from Divestiture of Businesses
DAVITA INC. (DVA) had Proceeds from Divestiture of Businesses of $4.47 billion as of 2019-06-19, per its 10-K filed 2022-02-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2022-02-11
- DAVITA INC. proceeds from divestiture of businesses for the quarter ending 2015-03-31 was $2.56M.
- DAVITA INC. proceeds from divestiture of businesses for the quarter ending 2014-09-30 was $3.40M.
- DAVITA INC. proceeds from divestiture of businesses for fiscal 2013 was $62.26M, a 1649.31% increase from fiscal 2012.
- DAVITA INC. proceeds from divestiture of businesses for fiscal 2012 was $3.56M.
| Period end | Proceeds from Divestiture of Businesses | Proceeds from Divestiture of Businesses 1 month | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 12 month |
|---|---|---|---|---|---|---|
| 2019-06-19 | $4.47B 10-K · filed 2022-02-11 | |||||
| 2017-12-31 | $4.90B 10-Q · filed 2018-08-01 | |||||
| 2015-03-31 | $2.56M 10-Q/A · filed 2015-05-08 | |||||
| 2014-09-30 | $3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $3.62M 10-Q · filed 2014-11-06 | ||||
| 2014-06-30 | $215.00K 10-Q · filed 2014-08-01 | |||||
| 2013-12-31 | $62.26M 10-K · filed 2015-02-26 | |||||
| 2012-12-31 | $3.56M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |